In the central nervous system, IDH mutant infiltrating gliomas (oligodendroglioma and IDH mutant astrocytoma) show significantly longer survival and better clinical outcomes than their IDH wild type counterparts (glioblastoma, IDH wild type) [19]. This evidence concerns the gene IDH1 and glioma.